Literature DB >> 376095

Combined chemotherapy cyclophosphamide, vinblastine, procarbazine and prednisone (CVPP) vs. CVPP plus CCNU (CCVPP) in Hodgin's disease.

M Morgenfeld, N Somoza, J Magnasco, S Pavlovsky, A C de Bonesana, R Bezares, A Suárez, J Pileggi, J M Lein, A Macchi, S I Calabria, G E Garay, S C de Sica, S Besuschio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376095     DOI: 10.1002/1097-0142(197905)43:5<1579::aid-cncr2820430502>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  [Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].

Authors:  R Kuse; A Calavrezos; A Hinrichs; K Hausmann
Journal:  Klin Wochenschr       Date:  1981-07-01

2.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06

3.  Influence of dose intensity and density on therapeutic and toxic effects in Hodgkin's disease.

Authors:  P Lagarde; F Bonichon; H Eghbali; I de Mascarel; J Chauvergne; B Hoerni
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.